Connacht Asset Management LP
- SEC CIK
- 0001802462
- Latest filing
- Nov 14, 2023
XENE holding history
Xenon Pharmaceuticals Inc. in every 13F filed by Connacht Asset Management LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
XENE overviewAll 13F holders of XENEFull Q3 2023 holdings
- Shares (Q3 2023)
- 8,204
- Value
- $280.2K
- % of portfolio
- 1.7%
- Quarters held
- 3
- Since Q1 2023